Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses | Semantic Scholar
Bone Metastases from Prostate Cancer: Hormonal Therapy | Oncohema Key
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity - Atherosclerosis
Androgens - drdhriti
Is hormonal treatment still an option in acne today? - Bettoli - 2015 - British Journal of Dermatology - Wiley Online Library
Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5 | BMC Cancer | Full Text
Cyproterone acetate - Wikipedia
References in Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial - The
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
Molecules | Free Full-Text | Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions | HTML
Cyproterone + Ethinylestradiol: Indication, Dosage, Side Effect, Precaution | MIMS Hong Kong
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer | British Journal of Cancer
Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial - The Journal of Sexual Medicine
Cyproterone acetate: Uses, Interactions, Mechanism of Action | DrugBank Online
Anti-androgen hormonal therapy for cancer and other diseases - ScienceDirect
Androgen receptor antagonists for prostate cancer therapy in: Endocrine-Related Cancer Volume 21 Issue 4 (2014)